Biotechnological Applications in Medicine — Revision Notes

⚡ 30-Second Revision

Recombinant Human Insulin: — Produced in *E. coli*; A & B chains synthesized separately, joined by disulfide bonds. First product: Humulin (Eli Lilly, 1983).
Gene Therapy: — Corrects defective genes. First successful case: ADA deficiency (SCID) in 1990, 4-year-old girl. Uses viral vectors (e.g., retrovirus) to introduce functional gene.
Molecular Diagnostics:

- PCR: Amplifies DNA/RNA. Used for early detection of pathogens (HIV, COVID-19, TB) due to high sensitivity. - ELISA: Detects antigens or antibodies via antigen-antibody interaction. Used for HIV diagnosis, blood screening.

Transgenic Animals: — Animals with altered genomes.

- Biopharming: Produce therapeutic proteins (e.g., human alpha-lactalbumin from Rosie the cow). - Disease Models: Study human diseases (cancer, cystic fibrosis). - Vaccine Safety Testing: Test vaccine safety/efficacy (e.g., polio vaccine on transgenic mice).

Ethical Concerns: — Germline alteration, 'designer babies', animal welfare.

2-Minute Revision

Biotechnological applications in medicine have transformed healthcare. Recombinant DNA technology allows for the mass production of therapeutic proteins like human insulin, which is identical to natural insulin, eliminating allergic reactions and ensuring abundant supply.

Recombinant vaccines, such as the Hepatitis B vaccine, offer safer alternatives by using only specific antigens. Gene therapy provides a potential cure for genetic disorders by introducing functional genes; the first successful case treated a 4-year-old girl with ADA deficiency (SCID) in 1990, using viral vectors to deliver the functional ADA gene into lymphocytes.

Molecular diagnostics, including PCR and ELISA, enable early and accurate disease detection. PCR amplifies pathogen DNA/RNA, crucial for early viral or bacterial infection diagnosis, while ELISA detects antigens or antibodies, useful for HIV screening.

Transgenic animals are engineered for various medical purposes: as 'bioreactors' to produce pharmaceuticals (e.g., human proteins in milk), as models to study human diseases, and for testing the safety of vaccines and drugs.

Ethical considerations surrounding gene therapy (germline alteration) and transgenic animals are also important aspects of this field.

5-Minute Revision

Biotechnology has revolutionized medicine through several key applications. Firstly, therapeutic protein production using recombinant DNA technology is paramount. The most notable example is recombinant human insulin (Humulin), developed by Eli Lilly in 1983.

This involves synthesizing the A and B chains of human insulin, inserting them into separate *E. coli* plasmids, producing the chains, and then chemically joining them via disulfide bonds. This method provides a safe, abundant, and non-immunogenic alternative to animal-derived insulin.

Similarly, recombinant vaccines (e.g., Hepatitis B vaccine) are safer as they use only specific antigens, not the whole pathogen.

Secondly, gene therapy offers a groundbreaking approach to treating genetic diseases. The first successful clinical gene therapy was performed in 1990 on a 4-year-old girl with Adenosine Deaminase (ADA) deficiency, a cause of SCID. This involved isolating lymphocytes, introducing a functional ADA cDNA using a retroviral vector, and reintroducing the modified cells. While initially requiring periodic infusions, the long-term goal is germline gene therapy for a permanent cure.

Thirdly, molecular diagnostics have enhanced disease detection. Polymerase Chain Reaction (PCR) is highly sensitive, amplifying even minute quantities of pathogen DNA/RNA, making it ideal for early detection of infections like HIV, TB, and COVID-19. ELISA (Enzyme-Linked Immunosorbent Assay) detects antigens or antibodies based on specific interactions, widely used for HIV diagnosis and blood screening.

Finally, transgenic animals play diverse roles. They serve as bioreactors to produce human proteins (e.g., 'Rosie' the cow producing human alpha-lactalbumin). They are invaluable as disease models (e.

g., transgenic mice for cancer, cystic fibrosis) to study disease progression and test new drugs. They are also used for vaccine safety testing, providing sensitive models to evaluate vaccine efficacy and side effects.

Ethical concerns, particularly regarding germline gene therapy and animal welfare, remain crucial considerations in this rapidly advancing field.

Prelims Revision Notes

1
Recombinant Human Insulin:

* First product: Humulin (Eli Lilly, 1983). * Process: Human insulin gene (A and B chains) inserted into *E. coli* plasmids separately. Chains produced, extracted, and joined by disulfide bonds. * Advantage: Identical to human insulin, no allergic reactions, abundant supply.

1
Gene Therapy:

* Definition: Introduction of functional gene to correct a defective one. * First Case: 1990, 4-year-old girl with Adenosine Deaminase (ADA) deficiency (causes SCID). * Method for ADA: Lymphocytes isolated, functional ADA cDNA introduced via retroviral vector, reintroduced into patient. Requires periodic infusions. Permanent cure aims at bone marrow cells.

1
Molecular Diagnostics:

* Purpose: Early and accurate detection of diseases. * PCR (Polymerase Chain Reaction): * Principle: Amplifies specific DNA/RNA sequences. * Application: Detects pathogens (HIV, TB, COVID-19) even at low concentrations, genetic mutations.

* Advantage: High sensitivity. * ELISA (Enzyme-Linked Immunosorbent Assay): * Principle: Antigen-antibody interaction. * Application: Detects antigens (pathogen components) or antibodies (host response).

Used for HIV diagnosis, blood screening.

1
Transgenic Animals:

* Definition: Animals with foreign gene (transgene) inserted into genome. * Applications: * Biopharming: Production of biological products (e.g., 'Rosie' the cow produced human alpha-lactalbumin-enriched milk). * Disease Models: Study human diseases (cancer, cystic fibrosis, Alzheimer's) and test treatments. * Vaccine Safety Testing: Test safety/efficacy of vaccines (e.g., polio vaccine on transgenic mice).

1
Ethical Issues:

* Gene Therapy: Germline gene therapy (heritable changes), 'designer babies', equity of access. * Transgenic Animals: Animal welfare, moral implications of genetic manipulation.

Vyyuha Quick Recall

To remember the key applications of medical biotechnology, think of 'G.I.M.P.T.':

Gene Therapy (e.g., ADA deficiency)
Insulin (Recombinant Human Insulin)
Molecular Diagnostics (e.g., PCR, ELISA)
Pharmaceuticals (other recombinant proteins, vaccines)
Transgenic Animals (for products, models, testing)